Latest Ragweed Stories
DC, MA, MI, NJ, NY, NC, OH, PA, RI, VA, WV, CA and TX analyzed in NRDC web tool WASHINGTON, Aug.
North Carolina State University researchers have found that a subset of fungus-farming ambrosia beetles may be in the early stages of a global epidemic threatening a number of economically important trees, including avocados, poplars and oaks.
MADISON, N.J., May 23, 2011 /PRNewswire/ -- Early results from the largest cross-sectional national allergy study ever conducted, to be released later this week, suggest that allergies have increased in America, but that most of the increase was due to two environmental allergens, ragweed and mold.
Warmer temperatures and later autumn frosts have been the main sources for why the ragweed allergy season in North America has grown two to four weeks longer than usual, according to researchers.
SAN ANTONIO, Jan. 13, 2011 /PRNewswire/ -- While the rest of the nation battles frigid cold and snow storms, South Texans are dealing with a massive blizzard of pollen.
Animals and plants introduced from foreign habitats may not seem harmful and can coexist with native species for decades, according to a European study published Monday.
OXFORD, England, September 30, 2010 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has further advanced the clinical development of three of its leading T-cell allergy vaccines.' In recent weeks, Circassia has initiated phase II clinical testing of its grass allergy (hayfever) therapy, begun the final stage of phase II testing with its ragweed allergy treatment and progressed phase III development plans for its cat allergy...
Being allergic to dogs or cats may worsen your ragweed allergies, according to a study from Queen's University.
Medication Delivered Under the Tongue May Be Alternative to Allergy Shots PITTSBURGH, Feb.
OXFORD, England, February 12 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial.